The center's research facilities, housed at Case, UH and CCF, will enable new non-embryonic stem cell research discoveries by faculty to be translated into therapies that can be used to treat thousands of patients each year.
In addition, the center's education programs will train personnel to perform groundbreaking research and deliver the world's foremost patient care.
"The importance of this new center's work will be incalculable," said Edward M. Hundert, M.D., president of Case, "not only in terms of lives potentially saved but in the hope it will offer. This is another example of the impact that Case, The Cleveland Clinic and University Hospitals of Cleveland can have when we continue to align our resources, talent and initiative."
The National Center for Regenerative Medicine builds on existing research at the three institutions that is supported by the National Institutes of Health and by the Ohio Wright Center of Innovation for Stem Cell and Regenerative Medicine involving Case, CCF and UHC. The Wright Center was established in 2003 through an investment by the State of Ohio as part of Gov. Bob Taft's Third Frontier Project. The Center institutions are nationally recognized in cell therapy for cancer and are rapidly translating new laboratory research into new therapies for heart disease, bone and joint disease and vascular disorders.
Congressman Ralph Regula (ROhio, 16th District), dean of the Ohio Congressional delegation and second highest-ranking Republican member of the House Appropriations Committee, played a pivotal role in securing this funding. Reg
Contact: George Stamatis
Case Western Reserve University